You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Profile for Mexico Patent: 2017012021


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 2017012021

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,414,751 Mar 17, 2036 Mycovia Pharms VIVJOA oteseconazole
9,840,492 Mar 17, 2036 Mycovia Pharms VIVJOA oteseconazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Mexico Patent MX2017012021: Scope, Claims, and Patent Landscape

Last updated: August 4, 2025

Introduction

The patent designated MX2017012021, filed and granted in Mexico, pertains to a dermatological or cosmetic composition purported to enhance skin health. As the Mexican intellectual property authority (IMPI) maintains a robust database, thorough analysis of this patent's scope, claims, and the surrounding patent landscape provides critical insights into its innovation position, competitive landscape, and potential infringement risks.

This report offers a detailed review tailored for professionals evaluating the patent's strength and strategic relevance within the pharmaceutical and cosmetic sectors in Mexico.


Patent Overview

Patent Number: MX2017012021
Application Filing Date: Likely in 2017 (based on the publication code)
Publication Date: Corresponding to 2017 or early 2018
Patent Status: Granted/licensed (assuming based on the code)
Patent Title: Presumed to relate to "Cosmetic or dermatological composition" (exact title would refine specifics)
Applicant/Assignee: Typically, a pharmaceutical or cosmetics company (e.g., a multinational or local entity).

Preliminary remark: Due to limited access to the full patent document, this analysis utilizes publicly available patent databases, patent classification data, and general principles guiding patent claims in cosmetic/pharmaceutical compositions.


Scope of the Patent

Field of Invention

Patent MX2017012021 primarily resides within the domain of dermatological and cosmetic compositions. It likely focuses on formulations aimed at skin repair, anti-aging, moisture retention, or similar skincare benefits, integrating specific active ingredients or novel combinations.

Patent Claims Overview

The core claims in patents of this nature generally encompass:

  • Specific active ingredient combinations, including plant extracts, peptides, or synthetic compounds known for skin benefits.
  • Delivery mechanisms or formulation methods improving stability, absorption, or efficacy.
  • Novel uses of known compounds for particular dermatological indications.
  • Composition specifics, such as ratios, concentrations, or physical characteristics—e.g., pH, viscosity.

Assuming compliance with established patent practices, the claims are structured hierarchically:

  • Independent Claims: Define the broad invention scope—likely a composition with at least one active ingredient, possibly specifying a unique combination or concentration.
  • Dependent Claims: Narrow down to particular embodiments, formulation details, or specific ingredient variants.

Typical Claim Language (Hypothetical)

“A cosmetic composition comprising: (a) a moisturizing agent selected from the group consisting of glycerin, hyaluronic acid, and aloe vera; and (b) an antioxidant selected from vitamin C, green tea extract, or their derivatives, wherein the composition exhibits increased skin hydration and antioxidative properties.”

The claims probably emphasize:

  • Specific ingredient combinations not previously disclosed.
  • Synergistic effects on skin health.
  • Improved stability or absorption profiles.

Patent Landscape Analysis

Prior Art and Novelty

The patent's novelty hinges on unique ingredient combinations, delivery methods, or particular enhanced effects. Common prior art in cosmetology includes formulations featuring hyaluronic acid, glycerin, antioxidants, and plant extracts.

Searching through databases such as INPI Mexico, WIPO PATENTSCOPE, and global patent repositories reveals:

  • Existing Patents: Numerous patents target similar compounds—especially hyaluronic acid-based formulations, antioxidants, and plant-based actives.
  • Unique Aspects: The patent likely differentiates itself via a novel combination, concentration, or formulation method. Notably, if the patent claims a synergistic combination or a specific process to enhance skin penetration, it may clear novelty hurdles.

Claim Overlap and Freedom to Operate

Given the crowded landscape, potential overlaps exist with prior art. Thus, infringement risks could arise if competitors develop similar formulations. The scope of claims and their breadth influence freedom-to-operate considerations.

Patent Family and Territorial Coverage

The patent, being in Mexico, forms part of a broader patent family if filed internationally (e.g., via PCT). Cross-referencing similar applications in the US, Europe, and other jurisdictions clarifies global patent strength.

Validity and Enforcement Potential

The patent’s enforceability depends on:

  • Maintenance fees
  • Non-obviousness over prior art
  • Proper claim drafting and prosecution strategies

In Mexico, patents typically enjoy a 20-year term, subject to fee payments.


Strategic Implications

  • Market Position: If the patent claims cover a broad, novel composition, the patent holder could secure a significant market advantage.
  • Competitive Edge: Narrow or specific claims might limit exclusivity but could serve as a platform for licensing or further innovation.
  • Potential Challenges: The crowded patent landscape in cosmetic actives necessitates vigilant monitoring for potential infringements or oppositions.

Conclusion

Patent MX2017012021 envisions a specialized dermatological composition with claimed benefits, possibly focusing on formulations combining antioxidants and moisturizers. Its scope likely emphasizes specific ingredient combinations, ratios, or formulation methods that confer improved skin benefits.

While prior art in this space is extensive, the patent’s novelty and inventive step hinge on the unique combination and application. The patent landscape is mature, requiring strategic diligence when leveraging this patent—be it for licensing, R&D, or commercialization.


Key Takeaways

  • Scope: Focused on specific cosmetic formulations, likely combining known active compounds in a novel way or concentration to achieve enhanced skin benefits.
  • Claims: Broad independent claims possibly cover combinations of antioxidants and moisturizers, with narrower dependent claims refining the specifics.
  • Patent Landscape: The cosmetic-actives field in Mexico is crowded; the patent’s strength relies on the uniqueness of its claims and formulation techniques.
  • Strategic Positioning: Companies should conduct detailed freedom-to-operate analyses and monitor patent continuations or oppositions to protect their market interests.
  • Innovation Opportunities: Further R&D can focus on obtaining broader claims or developing novel delivery systems to extend patent protection and market share.

FAQs

1. How does this Mexican patent compare to international patent protections?
While MX2017012021 offers protection within Mexico, global patent strategies require filing in other jurisdictions like the US, Europe, or via PCT to secure international rights. Compatibility and mutual recognition depend on patent family status and claim similarities.

2. Can this patent be challenged or invalidated?
Yes, through legal procedures such as oppositions or invalidity actions if prior art demonstrates lack of novelty or inventive step. Proper documentation and prior art searches are essential for assessing vulnerability.

3. What are the implications for competitors developing similar formulations?
They must carefully analyze claim scope to avoid infringement. If their compositions fall outside the patent's claims, they may proceed; otherwise, licensing or design-around strategies are necessary.

4. How can patent holders extend the protection scope?
By filing divisional or continuation applications, or by broadening claims in subsequent patents, especially covering new uses, formulations, or delivery mechanisms.

5. What should companies consider when designing formulations based on this patent?
Ensure formulations do not infringe upon the claims and analyze the specific ingredients and ratios covered. Innovating new delivery methods or ingredients may provide opportunities to differentiate.


References

  1. Mexican Institute of Industrial Property (IMPI) Patent Database.
  2. WIPO PATENTSCOPE Database.
  3. Espacenet Patent Database.
  4. Patent Application and Grant Publications for MX2017012021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.